Avidity Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Avidity Biosciences, Inc. (RNA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.220.190.340.320.33
Short-Term Investments1.280.410.270.090.01
Cash & Short-Term Investments1.500.600.610.410.33
Accounts Receivable0.030.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.010.010.010.000.00
Total Current Assets1.540.610.620.410.33
Non-Current Assets
Property, Plant & Equipment (Net)0.020.020.020.020.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.020.020.020.020.00
Total Assets1.560.630.640.430.33
Current Liabilities
Accounts Payable0.010.010.000.000.01
Short-Term Debt0.000.000.000.000.00
Accrued Liabilities0.060.030.040.020.00
Deferred Revenue0.020.030.010.000.00
Other Current Liabilities0.060.000.000.000.00
Total Current Liabilities0.100.080.050.030.01
Non-Current Liabilities
Long-Term Debt0.000.010.010.010.00
Other Non-Current Liabilities0.000.070.010.000.00
Total Non-Current Liabilities0.040.050.010.020.01
Total Liabilities0.140.130.060.050.03
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-0.89-0.57-0.36-0.18-0.07
Accumulated Other Comprehensive Income0.000.000.000.000.00
Additional Paid-in Capital2.321.070.940.570.37
Shares Outstanding0.120.080.070.050.00
Total Stockholders' Equity1.420.500.580.380.31
Total Liabilities & Equity1.560.630.640.430.33